Novapump - About the company
Novapump is a series A company based in Jena (Germany), founded in 2012 by Ronald Reich. It operates as a Percutaneously implanted Cardiac assist device. Novapump has raised an undisclosed amount in funding from investors like HTGF, Beteiligungsmanagement Thuringen and Sparkasse Jena-Saale-Holzland. The company has 99 active competitors, including 58 funded and 13 that have exited. Its top competitors include companies like CVRx, Impulse Dynamics and CorWave.
Company Details
Novapump is developing non-invasive and percutaneous heart assist devices especially for right heart insufficiency. The company's products PERKAT is a self-expanding heart pump that can be implanted within minutes in case of an emergency and represents a solution to help critically ill patients with acute right heart insufficiencies more rapidly. The small diameter of PERKAT™ allows percutaneous implantation in only a few minutes through the leg vein via Seldinger technique and using an 18F sheath system. The PERKAT device can be implanted percutaneously with no need for surgical intervention therefore saving the patient additional strain. In 2015, NovaPump was awarded by a jury as one of the most exciting young life-science project concepts 2015 and was one of the winning concepts at the VentureLounge from CatCap in Munich.
- Website
- novapump.de
- Registered Address
- NovaPump GmbH Am Steinborn 103a 07749 Jena
Key Metrics
Founded Year
2012
Location
Jena, Germany
Stage
Series A
Latest Funding Round
Ranked
52nd among 99 active competitors
Employee Count
5 as on May 31, 2026
Legal entities associated with Novapump
Novapump is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Novapump Gmbh CIN: HRB508307 , Germany, Active | Sep 09, 2012 | - | - |
Sign up to download Novapump's company profile
Novapump's funding and investors
Novapump has raised funding over 3 rounds. Its first funding round was on Jul 31, 2013. Its latest funding round was a Series A round on Jun 03, 2020 for $*****. 2 investors participated in its latest round. Novapump has 3 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of Novapump:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 03, 2020 | 3644347 | Series A | 6866503 | 7594892 | 2811252 | 8783317 |
Dec 14, 2015 | 9412494 | Series A | 3898827 | 2799453 | 9594494 | 2607518 |
Jul 31, 2013 | 8226515 | Seed | 5813329 | 3488540 | 5137476 |
Access funding benchmarks and valuations. Sign up today!View details of Novapump's funding rounds and investors
Novapump's founders and board of directors
Founder? Claim ProfileThe founders of Novapump is Ronald Reich.
Here are the details of Novapump's key team members:
- Ronald Reich: Founder & CEO of Novapump.
View details of Novapump's Founder profiles and Board Members
Novapump's employee count trend
Novapump has 5 employees as of May 26. Here is Novapump's employee count trend over the years:
Uncover Novapump's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Novapump's Competitors and alternates
Top competitors of Novapump include CVRx, Impulse Dynamics and CorWave. Here is the list of Top 10 competitors of Novapump, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | CVRx 2001, Minneapolis (United States), Public | Developer of implantable technology for hypertension and heart failure | $394M | 68/100 | |
2nd | Impulse Dynamics 1998, Marlton (United States), Series F | Provider of implantable device for treatment of chronic heart failure | $685M | 64/100 | |
3rd | Developer of implantable blood pumps for the treatment of heart failure | $127M | 61/100 | ||
4th |  Element Science 2013, San Francisco (United States), Series C | Wearable therapeutic device for treating sudden cardiac arrest | $193M | 61/100 | |
5th | SynCardia 2001, Tucson (United States), Public | Artificial heart | $72M | 60/100 | |
6th | Restore Medical 2016, Tel Aviv (Israel), Series B | Catheter-delivered implant for treatment of congestive heart failure | $32M | 58/100 | |
7th | InterShunt Technologies 2015, Louisiana (United States), Series B | Developer of cardiac catheter for the treatment of cardiac diseases | $26.6M | 57/100 | |
8th | Developer of an implantable cardiovascular device for treating heart failures | $51.9M | 57/100 | ||
9th | Corvia Medical 2009, Tewksbury (United States), Acquired | Developer of transcatheterally shunt for treating diastolic heart failure disease | $160M | 57/100 | |
10th | Reprieve Cardiovascular 2018, Milford (United States), Series B | Developer of decongestion management solution for acute decompensated heart failure patients | $150M | 56/100 | |
52nd | Percutaneously implanted Cardiac assist device | - | 32/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Novapump's competitors? Click here to see the top ones
Novapump's Investments and acquisitions
Novapump has made no investments or acquisitions yet.
Reports related to Novapump
Here is the latest report on Novapump's geography:
Are you a Founder ?
FAQs about Novapump
Explore our recently published companies
- Dnyhospitality - Unfunded company
- Doral SEO - Doral based, 2026 founded, Unfunded company
- EMJ - Italy based, 2026 founded, Unfunded company
- Gridwork - Delhi based, 2026 founded, Unfunded company
- Ekofusion - Sweden based, 2026 founded, Unfunded company
- Wise Widow - Charlotte based, 2026 founded, Unfunded company
